Hyper-IgD syndrome/mevalonate kinase deficiency: What is new?

62Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Mevalonate kinase deficiency or hyper-IgD syndrome is a hereditary autoinflammatory syndrome caused by mutations in the mevalonate kinase gene. In this review, we will discuss new findings in this disorder that have been published in the last 2 years. This includes new insights into pathophysiology, treatment, and the clinical phenotype linked to the genetic defect.

Cite

CITATION STYLE

APA

Mulders-Manders, C. M., & Simon, A. (2015, July 1). Hyper-IgD syndrome/mevalonate kinase deficiency: What is new? Seminars in Immunopathology. Springer Verlag. https://doi.org/10.1007/s00281-015-0492-6

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free